CRMD Q3 2022 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,817-82.1% YoY

Gross Profit

$5,34878.5% margin

Operating Income

-$7M-102126.1% margin

Net Income

-$7M-100538.7% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-67.9%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$983,524

Balance Sheet

Total Assets

$62M

Total Liabilities

$6M

Stockholders' Equity

$56M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6,817	$38,088	-82.1%
Gross Profit	$5,348	$12,922	-58.6%
Operating Income	-$7M	-$9M	+18.7%
Net Income	-$7M	-$9M	+20.0%